Evidence map›Paper›PMID 32762716›Full record

ArticleJournal of orthopaedic surgery and research2020

Atorvastatin promotes bone formation in aged apoE

Wei Hong, Zhanying Wei, Zhaohui Qiu, Zheng Li, Chensheng Fu, Zhibin Ye, Xiaoya Xu

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. [Study on the Mechanism by Which Atorvastatin Enhances the Stability of Atherosclerotic Plaques in ApoESichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Novel Role of the SIRT1 in Endocrine and Metabolic Diseases.International journal of biological sciences · 2023
    Review
  11. Review
  12. Association between Osteoporosis and Previous Statin Use: A Nested Case-Control Study.International journal of environmental research and public health · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wei HongDepartment of Osteoporosis and Bone Metabolism Disease, Huadong Hospital, Fu Dan University, Shanghai, China.
Zhanying WeiDepartment of Osteoporosis and Related Bone Disease, Shanghai 6th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhaohui QiuDepartment of Cardiology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zheng LiLaboratory Animal Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Chensheng FuDepartment of Nephrology, Huadong Hospital, Fudan University, Shanghai, China.
Zhibin YeDepartment of Nephrology, Huadong Hospital, Fudan University, Shanghai, China. yezb2013@163.com.
Xiaoya XuShanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, Shanghai, China. xiaoyaxu@fudan.edu.cn.
Fudan University · CNShanghai Jiao Tong University · CNTongren Hospital · CNZhongshan Hospital · CN

Funding

National Natural Science Foundation of China 81102071Shanghai Municipal Health Commission 201740028
6 · The paper itself

Abstract

backgroundStatins are the most widely used drugs in elderly patients; the most common clinical application of statins is in aged hyperlipemia patients. There are few studies on the effects and mechanisms of statins on bone in elderly mice with hyperlipemia. The study is to examine the effects of atorvastatin on bone phenotypes and metabolism in aged apolipoprotein E-deficient (apoE

methodsTwenty-four 60-week-old apoE

resultsThe results showed that long-term administration of atorvastatin increases bone mass and improves bone microarchitecture in trabecular bone but not in cortical bone. Furthermore, the serum bone formation marker osteocalcin (OCN) was ameliorated by atorvastatin, whereas the bone resorption marker tartrate-resistant acid phosphatase 5b (Trap5b) did not appear obviously changes after the treatment of atorvastatin. The mRNA expression of Sirt1, runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and OCN in bone tissue were increased after atorvastatin administration. Western blot showed same trend in Sirt1 and Runx2. The in vitro study showed that when BMSCs from apoE

conclusionsAccordingly, the current study validates the hypothesis that atorvastatin can increase bone mass and promote osteogenesis in aged apoE

Indexed as

Administration, OralAgedAlkaline PhosphataseAnimalsApolipoproteins EAtorvastatinBone and BonesBone DensityCancellous BoneCarbazolesCell DifferentiationCore Binding Factor Alpha 1 SubunitHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMesenchymal Stem Cells6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideAlkaline PhosphataseApolipoproteins EAtorvastatinCarbazolesCore Binding Factor Alpha 1 SubunitHydroxymethylglutaryl-CoA Reductase InhibitorsOsteocalcinRunx2 protein, mouseSirt1 protein, mouseSirtuin 1AgedApoE−/− miceAtorvastatinBone formationSirt1

Identifiers

PMID32762716
PMCPMC7412819
OpenAlexW3047214968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.